Inheret

• David Freeman Keren

Sources: reporter.nih.gov

• National Cancer Institute

  R42, InheRET: A SaaS solution to identify patients at increased risk for hereditary disease., R42CA239842, $996K, 2019–2023, Aug 20, 2021

• National Cancer Institute

  R41, InheRET: A SaaS solution to identifying patients at increased risk for hereditary disease, R41CA239842, $300K, 2019–2020, Mar 22, 2019

Sources: reporter.nih.gov